tradingkey.logo


tradingkey.logo


Venus Concept Inc

VERO
1.140USD
0.0000.00%
終倀 03/30, 16:00ET15分遅れの株䟡
2.12M時䟡総額
損倱額盎近12ヶ月PER


詳现情報 Venus Concept Inc 䌁業名

Venus Concept Inc. is a global medical technology company. The Company develops, commercializes and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services and reaches over 60 countries and nine direct markets. The Company’s product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa Pro, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Its treatments for hair loss are divided into non-surgical options and surgical procedures. Its hair restoration systems include NeoGraft and the ARTAS iX Robotic Hair Restoration system. Its systems are designed on flexible platforms that enable it to expand beyond the aesthetic industry’s traditional markets of dermatology and plastic surgery, and into non-traditional markets, including family medicine and general practitioners and aesthetic medical spas.

Venus Concept Incの䌁業情報


䌁業コヌドVERO
䌚瀟名Venus Concept Inc
䞊堎日Oct 12, 2017
最高経営責任者「CEO」De Silva (Rajiv D)
埓業員数292
蚌刞皮類Ordinary Share
決算期末Oct 12
本瀟所圚地235 Yorkland Blvd Suite 900
郜垂TORONTO
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜Canada
郵䟿番号M2J 4Y8
電話番号18778488430
りェブサむトhttps://www.venusconcept.com/en-uk/
䌁業コヌドVERO
䞊堎日Oct 12, 2017
最高経営責任者「CEO」De Silva (Rajiv D)

Venus Concept Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--
Ms. Melissa Kang, CPA
Ms. Melissa Kang, CPA
Chief Product Officer
Chief Product Officer
--
--
Ms. Louise M. Lacchin
Ms. Louise M. Lacchin
Independent Director
Independent Director
--
--
Dr. Anthony J. (Tony) Natale, M.D.
Dr. Anthony J. (Tony) Natale, M.D.
Independent Director
Independent Director
--
--
Mr. Scott Barry
Mr. Scott Barry
Independent Chairman of the Board
Independent Chairman of the Board
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Dr. Stanley Tyler Hollmig, M.D.
Dr. Stanley Tyler Hollmig, M.D.
Independent Director
Independent Director
1.76K
--
Mr. Kirk Gunhus
Mr. Kirk Gunhus
Chief Revenue Officer
Chief Revenue Officer
1.64K
--
Mr. Ross J. Portaro
Mr. Ross J. Portaro
Executive Vice President - Commercial Strategy and Head - Venus Hair
Executive Vice President - Commercial Strategy and Head - Venus Hair
812.00
--
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
Independent Director
Independent Director
753.00
+0.13%
Ms. Anna Georgiadis
Ms. Anna Georgiadis
Chief Human Resources Officer
Chief Human Resources Officer
157.00
+0.64%
Mr. Michael Mandarello
Mr. Michael Mandarello
Chief Legal Officer, Head of Strategy & Operations
Chief Legal Officer, Head of Strategy & Operations
136.00
--

収益内蚳

通貚: USD曎新時刻: Tue, Jan 6
通貚: USD曎新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
䌚瀟名
収益
比率
Products—Systems
7.86M
57.06%
Subscription—Systems
2.94M
21.31%
Products—Other
2.33M
16.93%
Services
647.00K
4.70%
地域別USD
䌚瀟名
収益
比率
United States
7.49M
54.36%
International
6.29M
45.64%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Products—Systems
7.86M
57.06%
Subscription—Systems
2.94M
21.31%
Products—Other
2.33M
16.93%
Services
647.00K
4.70%

株䞻

曎新時刻: Wed, Mar 18
曎新時刻: Wed, Mar 18
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Virtu Americas LLC
0.56%
Madryn Asset Management, LP
0.55%
他の
85.88%
株䞻統蚈
株䞻統蚈
比率
Orca Capital GmbH
5.47%
EW Healthcare Partners
5.33%
HealthQuest Capital Management, L.P
2.22%
Virtu Americas LLC
0.56%
Madryn Asset Management, LP
0.55%
他の
85.88%
皮類
株䞻統蚈
比率
Venture Capital
7.54%
Investment Advisor
5.77%
Individual Investor
0.82%
Research Firm
0.57%
Private Equity
0.55%
Investment Advisor/Hedge Fund
0.33%
Hedge Fund
0.17%
他の
84.26%

機関投資家保有株


曎新時刻: Thu, Jan 1
曎新時刻: Thu, Jan 1
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q4
34
298.27K
16.04%
+102.48K
2025Q3
33
256.25K
13.78%
+62.51K
2025Q2
48
303.44K
16.32%
+73.80K
2025Q1
57
222.57K
25.52%
+13.74K
2024Q4
59
229.67K
34.82%
+28.01K
2024Q3
64
3.05M
44.61%
-537.66K
2024Q2
70
3.54M
52.45%
+304.55K
2024Q1
74
3.18M
52.95%
-445.34K
2023Q4
77
2.92M
53.20%
-420.44K
2023Q3
87
3.15M
119.91%
-295.52K
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Orca Capital GmbH
101.75K
5.47%
+101.75K
--
Jun 06, 2025
EW Healthcare Partners
99.02K
5.33%
--
--
Sep 30, 2025
HealthQuest Capital Management, L.P
41.19K
2.22%
--
--
Dec 31, 2024
Madryn Asset Management, LP
10.19K
0.55%
--
--
Dec 11, 2025
De Silva (Rajiv)
7.58K
0.41%
--
--
Apr 28, 2025
Geode Capital Management, L.L.C.
6.12K
0.33%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
7.79K
0.42%
+7.79K
--
Sep 30, 2025
Tower Research Capital LLC
1.94K
0.1%
-1.98K
-50.45%
Sep 30, 2025
Hollmig (Stanley Tyler)
1.76K
0.09%
--
--
Apr 28, 2025
詳现を芋る

関連ETF


銘柄名
比率
デヌタなし

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
配圓萜ち日
皮類
比率
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
日付
配圓萜ち日
皮類
比率
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
Feb 27, 2025
Merger
11→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
May 11, 2023
Merger
15→1
KeyAI
î™